Inotiv Inc Stock Performance
| NOTV Stock | USD 0.57 0.00 0.000002% |
The company retains a Market Volatility (i.e., Beta) of 2.8, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Inotiv will likely underperform. At this point, Inotiv Inc has a negative expected return of -1.17%. Please make sure to check out Inotiv's information ratio and kurtosis , to decide if Inotiv Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Inotiv Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2026. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors. ...more
1 | Inotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Wednesday, December 3, 2025 | 11/21/2025 |
2 | Why Inotiv Inc. stock could rally in 2025 - 2025 Performance Recap Consistent Growth Equity Picks - B NI V | 11/26/2025 |
3 | Disposition of 2000 shares by Neff R Matthew of Inotiv at 0.8853 subject to Rule 16b-3 | 12/01/2025 |
4 | Insights Ahead Inotivs Quarterly Earnings | 12/02/2025 |
5 | Inotiv Inc Q4 2025 Earnings Call Highlights Revenue Growth Amid Cybersecurity Challenges | 12/04/2025 |
6 | Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities | 12/11/2025 |
7 | Is Inotiv Inc. stock a safe investment in uncertain markets - Bond Market Stepwise Swing Trade Plans - ulpravda.ru | 01/08/2026 |
8 | Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery | 01/13/2026 |
9 | Acquisition by Andrea Castetter of 10000 shares of Inotiv at 0.5956 subject to Rule 16b-3 | 01/15/2026 |
| Begin Period Cash Flow | 21.4 M | |
| Total Cashflows From Investing Activities | -12.9 M |
Inotiv Relative Risk vs. Return Landscape
If you would invest 138.00 in Inotiv Inc on October 25, 2025 and sell it today you would lose (81.00) from holding Inotiv Inc or give up 58.7% of portfolio value over 90 days. Inotiv Inc is currently does not generate positive expected returns and assumes 7.1348% risk (volatility on return distribution) over the 90 days horizon. In different words, 64% of stocks are less volatile than Inotiv, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Inotiv Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Inotiv's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Inotiv Inc, and traders can use it to determine the average amount a Inotiv's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Based on monthly moving average Inotiv is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inotiv by adding Inotiv to a well-diversified portfolio.
Inotiv Fundamentals Growth
Inotiv Stock prices reflect investors' perceptions of the future prospects and financial health of Inotiv, and Inotiv fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Inotiv Stock performance.
| Return On Equity | -0.45 | ||||
| Return On Asset | -0.0298 | ||||
| Profit Margin | (0.13) % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 456.69 M | ||||
| Shares Outstanding | 34.37 M | ||||
| Price To Earning | 30.91 X | ||||
| Price To Book | 0.14 X | ||||
| Price To Sales | 0.04 X | ||||
| Revenue | 513.02 M | ||||
| Gross Profit | 120.98 M | ||||
| EBITDA | 24.75 M | ||||
| Net Income | (68.62 M) | ||||
| Cash And Equivalents | 21.24 M | ||||
| Cash Per Share | 0.83 X | ||||
| Total Debt | 409.02 M | ||||
| Debt To Equity | 0.60 % | ||||
| Current Ratio | 1.60 X | ||||
| Book Value Per Share | 3.96 X | ||||
| Cash Flow From Operations | (10.46 M) | ||||
| Earnings Per Share | (2.11) X | ||||
| Market Capitalization | 18.99 M | ||||
| Total Asset | 771.11 M | ||||
| Retained Earnings | (630.81 M) | ||||
| Working Capital | (362.19 M) | ||||
About Inotiv Performance
Evaluating Inotiv's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Inotiv has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Inotiv has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 42.86 | 43.11 | |
| Return On Tangible Assets | (0.18) | (0.17) | |
| Return On Capital Employed | (0.17) | (0.16) | |
| Return On Assets | (0.10) | (0.10) | |
| Return On Equity | (0.58) | (0.55) |
Things to note about Inotiv Inc performance evaluation
Checking the ongoing alerts about Inotiv for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Inotiv Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Inotiv Inc generated a negative expected return over the last 90 days | |
| Inotiv Inc has high historical volatility and very poor performance | |
| Inotiv Inc has some characteristics of a very speculative penny stock | |
| Inotiv Inc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 513.02 M. Net Loss for the year was (68.62 M) with profit before overhead, payroll, taxes, and interest of 120.98 M. | |
| Inotiv Inc currently holds about 21.24 M in cash with (10.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.83, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Inotiv Inc has a frail financial position based on the latest SEC disclosures | |
| Latest headline from globenewswire.com: Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery |
- Analyzing Inotiv's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Inotiv's stock is overvalued or undervalued compared to its peers.
- Examining Inotiv's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Inotiv's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Inotiv's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Inotiv's stock. These opinions can provide insight into Inotiv's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Inotiv Stock Analysis
When running Inotiv's price analysis, check to measure Inotiv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inotiv is operating at the current time. Most of Inotiv's value examination focuses on studying past and present price action to predict the probability of Inotiv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inotiv's price. Additionally, you may evaluate how the addition of Inotiv to your portfolios can decrease your overall portfolio volatility.